Amundi Asset Management US’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15
| Closed | -$4K | – | 1538 |
|
|
2020
Q3 | $4K | Hold |
15
| – | – | ﹤0.01% | 1561 |
|
|
2020
Q2 | $5K | Buy |
+15
| New | +$5K | ﹤0.01% | 1569 |
|
|
2019
Q4 | – | Sell |
-4,098
| Closed | -$1.12M | – | 1627 |
|
|
2019
Q3 | $1.12M | Sell |
4,098
-676
| -14% | -$185K | ﹤0.01% | 1200 |
|
|
2019
Q2 | $2.55M | Sell |
4,774
-1,825
| -28% | -$974K | ﹤0.01% | 1074 |
|
|
2019
Q1 | $3.33M | Sell |
6,599
-12,579
| -66% | -$6.34M | ﹤0.01% | 977 |
|
|
2018
Q4 | $9.46K | Sell |
19,178
-2
| -0% | -$1 | 0.01% | 677 |
|
|
2018
Q3 | $17.5M | Buy |
19,180
+411
| +2% | +$376K | 0.02% | 577 |
|
|
2018
Q2 | $13.7M | Buy |
18,769
+7,257
| +63% | +$5.32M | 0.02% | 631 |
|
|
2018
Q1 | $18.4M | Sell |
11,512
-1,095
| -9% | -$1.75M | 0.03% | 514 |
|
|
2017
Q4 | $11.3M | Buy |
+12,607
| New | +$11.3M | 0.02% | 647 |
|